SLC16A1 and neoplasm: MCT1 is expressed in the well-oxygenated areas of the tumor, whereas MCT4 expression is upregulated in hypoxic areas through hypoxia-inducible factor 1α (HIF-1α), that is a major regulator of adaptation to hypoxic stress widely associated with cancer progression [8, 24, 27, 32].